methylatropine bromide

A quaternary derivative of atropine that is less lipid soluble and hence produces fewer central nervous system actions; a cycloplegic. SYN: atropine methylbromide.

Medical dictionary. 2011.

Look at other dictionaries:

  • Methylatropine — Systematic (IUPAC) name (1R,5R) 3 [(3 hydroxy 2 phenylpropanoyl)oxy] 8,8 dimethyl 8 azoniabicyclo[3.2.1]octane Clinical data Pregnancy cat …   Wikipedia

  • Oxyphenonium bromide — Systematic (IUPAC) name 2 (2 Cyclohexyl 2 hydroxy 2 phenylacetoxy) N,N diethyl N methylethanaminium bromide Clinical data …   Wikipedia

  • Otilonium bromide — Systematic (IUPAC) name N,N Diethyl N methyl 2 (4 [2 (octyloxy)benzamido]benzoyloxy)ethanaminium bromide Clinical data AHFS/ …   Wikipedia

  • Cimetropium bromide — Systematic (IUPAC) name 9 Cyclopropylmethyl 7 (3 hydroxy 2 phenyl propionyloxy) 9 methyl 3 oxa 9 azonia tricyclo[3.3.1.02,4 Clinical data …   Wikipedia

  • Atropine — A drug obtained from belladonna that is administered via injection, eye drops, or in oral form to relax muscles by inhibiting nerve responses. Used to dilate the pupils and as an antispasmodic. From the Greek goddess Atropos, the oldest and… …   Medical dictionary

  • Anticholinergic — An anticholinergic agent is a substance that blocks the neurotransmitter acetylcholine in the central and the peripheral nervous system. An example of an anticholinergic is dicycloverine, and the classic example is atropine. Anticholinergics are… …   Wikipedia

  • Octatropine methylbromide — Systematic (IUPAC) name (endo) 8,8 dimethyl 8 azoniabicyclo[3.2.1]octan 3 yl] 2 propylpentanoate bromide Clinical data …   Wikipedia

  • Glycopyrrolate — Systematic (IUPAC) name 3 (2 cyclopentyl 2 hydroxy 2 phenylacetoxy) 1,1 dimethylpyrrolidinium Clinical data AHFS/Drugs.com …   Wikipedia

  • Atropine — Systematic (IUPAC) name …   Wikipedia

  • Hyoscyamine — Systematic (IUPAC) name (8 methyl 8 az …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.